Ubiquinol ameliorates endothelial dysfunction and increases expression of miRNA-34a in a rat model of pulmonary hypertension

Ubiquinol ameliorates endothelial dysfunction and increases expression of miRNA-34a in a rat model of pulmonary hypertension

Introduction: In this research, we evaluate the effect of intravenously administrated solubilized ubiquinol on 4-week monocrotalin-induced pulmonary hypertension (PH) in rats. Materials and methods: To reproduce the model, some male Wistar rats were subcutaneously injected with alco...

Full description

Bibliographic Details
Main Authors:	Tatyana A. Kuropatkina, Nadezda V. Pankova, Natalia A. Medvedeva, Oleg S. Medvedev
Format:	Article
Language:	English
Published:	Belgorod National Research University 2021-09-01
Series:	Research Results in Pharmacology
Online Access:	https://rrpharmacology.pensoft.net/article/67291/download/pdf/

Similar Items

Sex-Dependent Protective Effect of Combined Application of Solubilized Ubiquinol and Selenium on Monocrotaline-Induced Pulmonary Hypertension in Wistar Rats
by: Tatyana Kuropatkina, et al.
Published: (2022-03-01)

Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial
by: Jacopo Sabbatinelli, et al.
Published: (2020-04-01)

Ubiquinol Supplementation Improves Gender-Dependent Cerebral Vasoreactivity and Ameliorates Chronic Inflammation and Endothelial Dysfunction in Patients with Mild Cognitive Impairment
by: Sonia García-Carpintero, et al.
Published: (2021-01-01)

Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension
by: Csilla Fazakas, et al.
Published: (2018-05-01)

Hydrogen Inhalation Reduces Lung Inflammation and Blood Pressure in the Experimental Model of Pulmonary Hypertension in Rats
by: Tatyana Kuropatkina, et al.
Published: (2023-11-01)

Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats
by: Zhihong Lin, et al.
Published: (2017-08-01)

The Cocrystal of Ubiquinol: Improved Stability and Bioavailability
by: Qi Zhang, et al.
Published: (2023-10-01)

Circulating miRNAs as potential marker for pulmonary hypertension.
by: Chuanyu Wei, et al.
Published: (2013-01-01)

A glucagon-like peptide-1 analog, liraglutide, ameliorates endothelial dysfunction through miRNAs to inhibit apoptosis in rats
by: Qian Zhang, et al.
Published: (2019-03-01)

Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?
by: Kondababu Kurakula, et al.
Published: (2021-01-01)

Mechanisms Contributing to the Dysregulation of miRNA-124 in Pulmonary Hypertension
by: Hui Zhang, et al.
Published: (2021-04-01)

Endothelial phosphodiesterase 4B inactivation ameliorates endothelial-to-mesenchymal transition and pulmonary hypertension
by: Yanjiang Xing, et al.
Published: (2024-04-01)

Gut Microbiota and Biomarkers of Endothelial Dysfunction in Cirrhosis
by: Irina Efremova, et al.
Published: (2024-02-01)

Endothelial cell clonality, heterogeneity and dysfunction in pulmonary arterial hypertension
by: Geoffrey Newcomb, et al.
Published: (2023-12-01)

Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension
by: Jaylen Hudson, et al.
Published: (2021-11-01)

Identification of miRNA-34a and miRNA-155 as prognostic markers for mantle cell lymphoma
by: Jianxia He, et al.
Published: (2021-05-01)

Endothelial periostin regulates vascular remodeling by promoting endothelial dysfunction in pulmonary arterial hypertension
by: Dawn Lee, et al.
Published: (2024-12-01)

Glomerular endothelial derived vesicles mediate podocyte dysfunction: A potential role for miRNA.
by: N Hill, et al.
Published: (2020-01-01)

MiRNAs in Systemic Sclerosis Patients with Pulmonary Arterial Hypertension: Markers and Effectors
by: Mor Zaaroor Levy, et al.
Published: (2022-03-01)

Effect of Ubiquinol supplementation on ovulation induction in Clomiphene Citrate resistance
by: Islam Mohamed Magdi Ammar, et al.
Published: (2021-08-01)

A mouse model of familial ALS has increased CNS levels of endogenous ubiquinol9/10 and does not benefit from exogenous administration of ubiquinol10.
by: Jacopo Lucchetti, et al.
Published: (2013-01-01)

CircALMS1 Alleviates Pulmonary Microvascular Endothelial Cell Dysfunction in Pulmonary Hypertension
by: Xiaoyi Hu, et al.
Published: (2024-03-01)

The role of miRNA-34a as a prognostic biomarker for cirrhotic patients with portal hypertension receiving TIPS.
by: Christian Jansen, et al.
Published: (2014-01-01)

The Role of miRNA-221 and miRNA-34a in Non-Melanoma Skin Cancer of the Head and Neck Region
by: Tiberiu Tamas, et al.
Published: (2023-02-01)

Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease
by: Halla M. Ragab, et al.
Published: (2023-02-01)

Sinapine Thiocyanate Ameliorates Vascular Endothelial Dysfunction in Hypertension by Inhibiting Activation of the NLRP3 Inflammasome
by: Yang Liu, et al.
Published: (2021-02-01)

Cervical Cancer, Papillomavirus, and miRNA Dysfunction
by: Evelyn Gabriela Bañuelos-Villegas, et al.
Published: (2021-12-01)

Diagnostic value of miRNA expression and right ventricular echocardiographic functional parameters for chronic thromboembolic pulmonary hypertension with right ventricular dysfunction and injury
by: Ran Miao, et al.
Published: (2022-04-01)

Bioavailability of Reduced Coenzyme Q10 (Ubiquinol-10) in Burn Patients
by: Naohide Kuriyama, et al.
Published: (2022-07-01)

Ubiquinol-10 Intake Is Effective in Relieving Mild Fatigue in Healthy Individuals
by: Kei Mizuno, et al.
Published: (2020-06-01)

The effects of ubiquinol supplementation on clinical parameters and physical performance of trained men
by: Sumate Kunching, et al.
Published: (2022-02-01)

Hyperuricemia, endothelial dysfunction and hypertension
by: Daniela MIRICESCU, et al.
Published: (2020-06-01)

Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension
by: Joana Santos-Gomes, et al.
Published: (2022-03-01)

mutations and endothelial dysfunction in pulmonary arterial hypertension (2017 Grover Conference Series)
by: Andrea Frump, et al.
Published: (2018-04-01)

THE IMPORTANCE OF ENDOTHELIAL DYSFUNCTION FOR THE DEVELOPMENT OF PULMONARY ARTERIAL HYPERTENSION AND NEW THERAPEUTIC OPTIONS
by: Barbara Salobir, et al.
Published: (2003-06-01)

Hemin-Induced Endothelial Dysfunction and Endothelial to Mesenchymal Transition in the Pathogenesis of Pulmonary Hypertension Due to Chronic Hemolysis
by: Janae Gonzales, et al.
Published: (2022-04-01)

TREM2 signaling, miRNA-34a and the extinction of phagocytosis
by: Yuhai eZhao, et al.
Published: (2013-08-01)

Acid ceramidase gene therapy ameliorates pulmonary arterial hypertension with right heart dysfunction
by: Michael G. Katz, et al.
Published: (2023-08-01)

Association of Exosomal miR-34a with Markers of Dyslipidemia and Endothelial Dysfunction in Children and Adolescents with T1DM
by: Alshaymaa A. Ibrahim, et al.
Published: (2020-12-01)

Vildagliptin, a dipeptidyl peptidase-4 inhibitor, attenuated endothelial dysfunction through miRNAs in diabetic rats
by: Qian Zhang, et al.
Published: (2019-07-01)